TOCILIZUMAB

tocilizumab 200 mg/10 mL injection, 10 mL vial

TOCILIZUMAB (12791F)

tocilizumab 200 mg/10 mL injection, 10 mL vial
12791F
Body System:
Manner of administration:Injection
Public
S100 HSD Public
Authority Required

Restriction

Indication: Severe active rheumatoid arthritis
Treatment phase: Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 0 DPMQ: $200.71 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Actemra
Avtozma